These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 826969)

  • 1. Stimulant actions of delta9-tetrahydrocannabinol in mice.
    Evans MA; Harbison RD; Brown DJ; Forney RB
    Psychopharmacology (Berl); 1976 Nov; 50(3):245-50. PubMed ID: 826969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.
    Consroe P; Jones B; Laird H
    Psychopharmacology (Berl); 1976 Oct; 50(1):47-52. PubMed ID: 827761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine.
    Varvel SA; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 Sep; 193(4):511-9. PubMed ID: 17497137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.
    Castelli MP; Madeddu C; Casti A; Casu A; Casti P; Scherma M; Fattore L; Fadda P; Ennas MG
    PLoS One; 2014; 9(5):e98079. PubMed ID: 24844285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice.
    Ayhan IH; Kaymakçalan S; Tulunay FC
    Psychopharmacology (Berl); 1979 May; 63(2):169-72. PubMed ID: 112635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
    Wu X; French ED
    Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine.
    Glennon RA; Ismaiel AE; Martin B; Poff D; Sutton M
    Pharmacol Biochem Behav; 1988 Sep; 31(1):9-13. PubMed ID: 3252264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of delta 9-tetrahydrocannabinol on the morphine-induced hyperactivity of mice.
    Ulkü E; Ayhan IH; Tulunay FC; Uran B; Kaymakçalan S
    Psychopharmacology (Berl); 1980; 69(2):201-5. PubMed ID: 6256790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of cycloheximide on behavioral sensitization to methamphetamine in mice.
    Shimosato K; Saito T
    Eur J Pharmacol; 1993 Mar; 234(1):67-75. PubMed ID: 8472762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.
    Irimia C; Polis IY; Stouffer D; Parsons LH
    Psychopharmacology (Berl); 2015 Aug; 232(16):3033-43. PubMed ID: 25925779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THC and gabapentin interactions in a mouse neuropathic pain model.
    Atwal N; Casey SL; Mitchell VA; Vaughan CW
    Neuropharmacology; 2019 Jan; 144():115-121. PubMed ID: 30312630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.